Renal Cancer - Results from #5940

The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial November 19, 2015

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma. November 19, 2015

Renal cell carcinoma: review of etiology, pathophysiology and risk factors November 19, 2015

DNA damage response in cisplatin-induced nephrotoxicity November 19, 2015

Palliative Surgery for Advanced Cancer: Identifying Evidence-Based Criteria for Patient Selection: Case Report and Review of Literature November 17, 2015

Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features November 17, 2015

Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up November 16, 2015

Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcin November 13, 2015

Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden November 13, 2015

Exosomes as renal inductive signals in health and disease, and their application as diagnostic markers and therapeutic agents November 13, 2015

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma November 13, 2015

Metastatic renal cell carcinoma without evidence of a renal primary November 13, 2015

In Vitro Kinetic Characterization of Axitinib Metabolism November 13, 2015

The growth rate of "clinically significant" renal cancer November 11, 2015

[MiRNA-381 inhibits the invasion of renal carcinoma and  the underlying mechanisms]. November 11, 2015

Surgical considerations for patients with metastatic renal cell carcinoma November 10, 2015

Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis November 10, 2015

HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients With Cancer November 10, 2015

Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities November 10, 2015

Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy November 6, 2015

Page 298 of 456